EBOS Group Stock

EBOS Group CROIC

The Cash Return on Invested Capital (CROIC) of EBOS Group (EBO.NZ) as of Aug 19, 2026 is 6.25 %. In the previous year, Cash Return on Invested Capital (CROIC) was 5.60 % — a change of 11.51% (higher).

CROIC

6.25 %

YoY

11.51%

Last updated:

Cash Return on Invested Capital (CROIC) of EBOS Group is 2026 6.25 % . Cash Return on Invested Capital (CROIC) of EBOS Group was 2025 5.60 % . It decreases by 11.51% higher compared to the previous year.
Access this data via the Eulerpool API
Get Free API Key

EBOS Group Stock analysis

What does EBOS Group do? The EBOS Group was founded in New Zealand in 2000 and has since grown to become one of the largest healthcare companies in the region. The company's business model is to provide solutions for the healthcare industry, ranging from products for pharmacies, hospitals, and medical practices to healthcare services. The company is divided into several divisions, including healthcare distribution, dental, and healthcare services. The healthcare distribution division focuses on distributing pharmaceutical products, medical devices, and other healthcare items to healthcare facilities. This includes surgical instruments and oncology products. The dental division specializes in selling and distributing dental products, such as instruments for dentists and consumables like gloves, implants, and floss. They also offer services for dentists, including a dental practice built in partnership with another company. The healthcare services division includes the distribution of home care and healthcare products, as well as the rental of medical equipment like wheelchairs and beds. EBOS Group also provides services such as consultation and training for patients, caregivers, and healthcare providers. With a strong emphasis on quality and customer satisfaction, EBOS Group has a successful track record and has acquired and developed several companies in the region. Their products help improve patient health and contribute to reducing healthcare costs. The company plays a vital role in the healthcare products and services market. The EBOS Group's diverse divisions and wide range of products secure its position as an important player in the healthcare industry. EBOS Group is one of the most popular companies on Eulerpool.

Frequently Asked Questions about EBOS Group stock

Cash Return on Invested Capital (CROIC) of EBOS Group is 6.25 % in 2026.

Cash Return on Invested Capital (CROIC) of EBOS Group changed from 5.60 % to 6.25 %, representing a 11.51% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Cash Return on Invested Capital (CROIC) EBOS Group since 2006 – with annual values, charts, and detailed analysis.

CROIC measures the cash return generated on invested capital. Unlike ROIC, it uses free cash flow instead of accounting earnings, providing a purer profitability measure.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Cash Return on Invested Capital (CROIC)'s EBOS Group with sector peers and the industry average to assess whether it is attractive.

To evaluate Cash Return on Invested Capital (CROIC)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Cash Return on Invested Capital (CROIC).

Access this data via the Eulerpool API
Get Free API Key

Profitability — EBOS Group

ROEROAROCEROICAsset TurnoverInventory TurnoverReceivables TurnoverDays Sales OutstandingDays Inventory OutstandingDays Payable OutstandingCash Conversion CycleCROICGross Profit/AssetsFixed Asset TurnoverEquity TurnoverWorking Capital TurnoverPayables TurnoverCapital IntensityReceivables/RevenueInventory/RevenueEBIT/Assets

All Key Metrics — EBOS Group